Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents
Stopped early · Not applicable
Conditions studied: Depression in Adolescence
In brief
The MoodRing intervention is a mobile application for adolescents, parents, and an accompanying web-based clinician portal which enables adolescents to monitor their mood through the use of passively collected smartphone data. This randomized controlled trial will evaluate whether MoodRing as compared to usual care improves the quality of depression management.
Key facts
- Study ID
- NCT05376358
- Run by
- Ana Radovic
- People needed
- 73
- Starts
- 2022-05-12
- Expected to finish
- 2024-06-20
- Last updated by the study team
- 2025-08-14
Who can join
Age: 12 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adolescent:
- age 12 -18
- prior or present history of depression per self-report and/or clinician diagnosis
- scores between 5 or higher on PHQ-9 consistent with at least mild symptoms of depression
- read and understand English
- has an Android or iOS smartphone compatible with AWARE mobile application and access to a smartphone data plan
- currently in United States
- Parent/Guardian:
- adolescent qualifies for study and assents to enroll
- understands English
- currently in United States
- has a smartphone device that can download the intervention application
- Healthcare Provider:
- involved in providing mental health treatment (psychotherapy or antidepressant prescribing or making referrals) to adolescent participant - can be a primary care provider, therapist, subspecialist, psychiatrist
You may not qualify if…
- Adolescent:
- currently actively suicidal (have suicidal thoughts and plan with an intent to act on it)
- plans to travel to countries belonging to the European Union (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden), the United Kingdom (England, Scotland, Wales, and Northern Ireland), Norway, Iceland, or Lichtenstein in the next 6 months for more than 2 weeks at a time
- Parent:
- If their adolescent child is excluded
- Healthcare Provider:
- None
Where it is running
- Center for Adolescent and Young Adult Health — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.